Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country

被引：0

作者：

B. Dzingirai

C. M. J. Matyanga

T. Mudzviti

M. Siyawamwaya

D. Tagwireyi

机构：

[1] University of Zimbabwe,School of Pharmacy, College of Health Sciences

[2] University Medical Centre Groningen (UMCG),Institute of Science in Healthy Aging & Healthcare (SHARE)

[3] University of Zimbabwe,Clinical Pharmacology, College of Health Sciences

[4] Newlands Clinic,undefined

来源：

Journal of Pharmaceutical Policy and Practice | / 13卷

关键词：

COVID-19; Community pharmacists; Pharmacy personnel; Low-income country; Personal protective equipment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global pandemic. COVID-19 is spreading in Africa, and Zimbabwe has not been spared. The cases in Zimbabwe are mainly from imported cases due to high volume of travellers from the COVID-19 hotspots. In Zimbabwe, local transmission is also anticipated due to inter- and intracity travelling. Frontline health workers are at risk of infection due to contact with infected people as they discharge their duties. In this setting, the risk to community pharmacists and pharmacy personnel is poorly understood and characterised. This paper looked at the risks of infection that are peculiar to community pharmacy personnel and suggested some recommendations to reduce the risk to COVID-19 infection.

引用

共 25 条

[1]

Lu R(2020)Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet. 395 565-574

[2]

Zhao X(2020)The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status Mil Med Res 7 11-1720

[3]

Li J(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med. 382 1708-971

[4]

Guo Y(2020)Transmission of 2019-nCoV infection from an asymptomatic contact in Germany N Engl J Med. 382 970-733

[5]

Cao Q(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med. 382 727-273

[6]

Hong Z(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature. 579 270-189

[7]

Guan W(2020)Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: protocol for restricted public health emergency use Indian J Med Res. 151 184-172

[8]

Ni Z(2019)Pharmacist-led hypertension management combined with blood pressure telemonitoring in a primary care setting may be cost-effective in high-risk patients J Clin Hypertens. 21 169-30493

[9]

Hu Y(2020)Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures? [published online ahead of print, 2020 May 1] Res Social Adm Pharm. S1551-7411 30490-undefined

[10]

Rothe C(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 →